Table 1.
Correlation between the clinicopathological factors and expression of LINC00470 in astrocytoma
| Characteristic | Total(N=75) | LINC00470 high expression | LINC00470 low expression |
|---|---|---|---|
| Histologic grade*-no.(%) | |||
| Astrocytoma | |||
| I | 9(12) | 3(33) | 6(67) |
| II | 27(36) | 14(52) | 13(48) |
| III | 18(24) | 13(72) | 15(28) |
| IV | 21(28) | 17(81) | 4(19) |
| Sex-no.(%) | |||
| Male | 39(52) | 17(44) | 22(56) |
| Female | 36(48) | 21(58) | 15(42) |
| Age*-no.(%) | |||
| ≤42 | 31(41) | 10(33) | 21(67) |
| >42 | 44(54) | 35(80) | 9(20) |
| Tumor location*-no./total no.(%) | |||
| Frontal lobe | 23/72(32) | 9/23(39) | 14/23(61) |
| Parietal lobe | 19/72(26) | 6/19(32) | 13/19(68) |
| Temporal lobe | 13/72(19) | 10/13(77) | 3/13(23) |
| Brainstem | 3/72(4) | 2/3(66) | 1/3(34) |
| others | 14/72(19) | 7/17(50) | 7/17(50) |
| Laterality-no./total no.(%) | |||
| Left | 32/72(44) | 15/33(47) | 17/33(53) |
| Right | 25/72(35) | 10/26(38) | 16/26(62) |
| others | 15/72(21) | 7/16(43) | 9/16(57) |
| Presenting symptom-no./total no.(%) | |||
| Seizure | 38/70(54) | 21/38(55) | 17/38(45) |
| Headache | 12/70(17) | 6/12(50) | 6/12(50) |
| Sensory or visual change | 9/70(13) | 5/9 (56) | 4/9(44) |
| Mental statue change | 11/70(16) | 6/11(55) | 5/11(45) |
Categorical distributions were compared with the use of Fisher’s exact test.
*P<0.01 for the difference among the molecular subtypes.